OC.08.2 THE FXR AGONIST, OBETICHOLIC ACID, INHIBITS THE CANCEROGENIC POTENTIAL OF PRIMARY HUMAN CHOLANGIOCARCINOMA CELLS: A STUDY ON PRIMARY HUMAN CELL CULTURES. Issue 2 (15th March 2018)